{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:44:53Z","timestamp":1785282293581,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijid.2026.108752","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:08:14Z","timestamp":1777590494000},"page":"108752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Do the protein-based meningococcal group B vaccines, 4CMenB and MenB-fHbp, elicit serum bactericidal antibody against meningococcal serogroup X clonal complex 181?"],"prefix":"10.1016","volume":"169","author":[{"given":"Kelly","family":"Townsend-Payne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleema","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Mabey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Linley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108752_bib0001","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1474-4422(18)30387-9","article-title":"Global, regional, and national burden of meningitis, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Zunt","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ijid.2026.108752_bib0002","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3201\/eid1904.111799","article-title":"Description and nomenclature of Neisseria meningitidis capsule locus","volume":"19","author":"Harrison","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2026.108752_bib0003","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2026.108752_bib0004","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12879-019-4146-5","article-title":"Invasive meningococcal disease in patients with complement deficiencies: a case series (2008\u20132017)","volume":"19","author":"Ladhani","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.ijid.2026.108752_bib0005","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/infdis\/jiz355","article-title":"Meningococcal meningitis outbreaks in the African meningitis belt after meningococcal serogroup A conjugate vaccine introduction, 2011\u20132017","volume":"220","author":"Fernandez","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108752_bib0006","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3201\/eid2204.150653","article-title":"Neisseria meningitidis serogroup X in sub-Saharan Africa","volume":"22","author":"Agnememel","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2026.108752_bib0007","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa2013615","article-title":"Meningococcal serogroup ACWYX conjugate vaccine in Malian toddlers","volume":"384","author":"Tapia","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108752_bib0008","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1186\/s12982-025-00592-9","article-title":"Nigeria introduces the world\u2019s first Men5 CV meningitis vaccine","volume":"22","author":"Aderinto","year":"2025","journal-title":"Discov Public Health"},{"key":"10.1016\/j.ijid.2026.108752_bib0009","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s40121-024-01063-5","article-title":"Global epidemiology of meningococcal disease-causing serogroups before and after the COVID-19 pandemic: a narrative review","volume":"13","author":"Shen","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijid.2026.108752_bib0011","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2357924","article-title":"4CMenB journey to the 10-year anniversary and beyond","volume":"20","author":"Abitbol","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2026.108752_bib0012","doi-asserted-by":"crossref","first-page":"e1661","DOI":"10.1093\/cid\/ciaa1244","article-title":"First real-world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease: prospective enhanced national surveillance, England","volume":"73","author":"Ladhani","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108752_bib0013","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3201\/eid2305.161713","article-title":"Meningococci of serogroup X clonal complex 181 in refugee camps","volume":"23","author":"Stefanelli","year":"2017","journal-title":"Italy. Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2026.108752_bib0014","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.3390\/microorganisms12122528","article-title":"Characterization of unusual serogroups of Neisseria meningitidis","volume":"12","author":"Taha","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijid.2026.108752_bib0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jinf.2011.11.009","article-title":"Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates","volume":"64","author":"Vicente","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2026.108752_bib0016","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3201\/eid1602.091553","article-title":"Neisseria meningitidis serogroup X sequence type 2888","volume":"16","author":"Fazio","year":"2010","journal-title":"Italy. Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2026.108752_bib0017","series-title":"Handbook of meningococcal disease","first-page":"323","article-title":"Surrogates of protection","author":"Borrow","year":"2006"},{"key":"10.1016\/j.ijid.2026.108752_bib0018","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.vaccine.2012.12.022","article-title":"Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?","volume":"31","author":"Hong","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108752_bib0019","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1080\/21645515.2020.1855951","article-title":"Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy","volume":"17","author":"Fazio","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2026.108752_bib0020","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.vaccine.2018.05.081","article-title":"The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci","volume":"36","author":"Harris","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108752_bib0021","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1473-3099(18)30400-6","article-title":"Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study","volume":"18","author":"Chen","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108752_bib0022","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(25)00046-7","volume":"405","author":"Diallo","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108752_bib0023","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1016\/j.vaccine.2014.09.063","article-title":"Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt","volume":"32","author":"Tunheim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108752_bib0024","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41541-024-00935-8","article-title":"A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine","volume":"9","author":"Kim","year":"2024","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.ijid.2026.108752_bib0025","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.vaccine.2015.05.027","article-title":"Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers","volume":"33","author":"Findlow","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108752_bib0026","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4939-9202-7_12","article-title":"Meningococcal serogroup A, B, C, W, X, and Y serum bactericidal antibody assays","volume":"1969","author":"Lucidarme","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijid.2026.108752_bib0027","series-title":"R: a language and environment for statistical computing","year":"2026"},{"key":"10.1016\/j.ijid.2026.108752_bib0028","author":"Ogle"},{"key":"10.1016\/j.ijid.2026.108752_bib0029","series-title":"An R Companion to applied regression","author":"Fox","year":"2019"},{"key":"10.1016\/j.ijid.2026.108752_bib0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","article-title":"The global meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","volume":"16","author":"Borrow","year":"2017","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.ijid.2026.108752_bib0031","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/INF.0000000000001124","volume":"35","author":"Muse","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2026.108752_bib0032","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1016\/j.vaccine.2022.08.013","article-title":"Validation and use of a serum bactericidal antibody assay for Neisseria meningitidis serogroup X in a seroprevalence study in Niger, West Africa","volume":"40","author":"Katz","year":"2022","journal-title":"Vaccine"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:42:20Z","timestamp":1781577740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226003875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S1201971226003875"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108752","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do the protein-based meningococcal group B vaccines, 4CMenB and MenB-fHbp, elicit serum bactericidal antibody against meningococcal serogroup X clonal complex 181?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108752"}}